Kurs
-1,59%
Likviditet
0,21 MSEK
Prenumeration
Kalender
Est. tid* | ||
2026-02-20 | 07:30 | Bokslutskommuniké 2025 |
2025-11-07 | 07:30 | Kvartalsrapport 2025-Q3 |
2025-08-21 | 07:30 | Kvartalsrapport 2025-Q2 |
2025-05-28 | N/A | X-dag ordinarie utdelning PLUN 0.00 SEK |
2025-05-27 | N/A | Årsstämma |
2025-05-16 | 07:30 | Kvartalsrapport 2025-Q1 |
2025-02-20 | - | Bokslutskommuniké 2024 |
2024-12-23 | - | Split PLUN 40:1 |
2024-12-05 | - | Extra Bolagsstämma 2024 |
2024-11-07 | - | Kvartalsrapport 2024-Q3 |
2024-08-19 | - | Kvartalsrapport 2024-Q2 |
2024-05-31 | - | X-dag ordinarie utdelning PLUN 0.00 SEK |
2024-05-30 | - | Årsstämma |
2024-05-16 | - | Kvartalsrapport 2024-Q1 |
2024-02-16 | - | Bokslutskommuniké 2023 |
2023-11-07 | - | Kvartalsrapport 2023-Q3 |
2023-10-12 | - | Extra Bolagsstämma 2023 |
2023-07-14 | - | Kvartalsrapport 2023-Q2 |
2023-05-17 | - | Kvartalsrapport 2023-Q1 |
2023-05-05 | - | X-dag ordinarie utdelning PLUN 0.00 SEK |
2023-05-04 | - | Årsstämma |
2023-02-15 | - | Bokslutskommuniké 2022 |
2022-10-21 | - | Kvartalsrapport 2022-Q3 |
2022-07-14 | - | Kvartalsrapport 2022-Q2 |
2022-05-06 | - | X-dag ordinarie utdelning PLUN 0.00 SEK |
2022-05-05 | - | Årsstämma |
2022-05-05 | - | Kvartalsrapport 2022-Q1 |
2022-02-18 | - | Bokslutskommuniké 2021 |
2021-10-22 | - | Kvartalsrapport 2021-Q3 |
2021-08-19 | - | Kvartalsrapport 2021-Q2 |
2021-05-12 | - | X-dag ordinarie utdelning PLUN 0.00 SEK |
2021-05-11 | - | Årsstämma |
2021-05-07 | - | Kvartalsrapport 2021-Q1 |
2021-02-19 | - | Bokslutskommuniké 2020 |
2020-10-23 | - | Kvartalsrapport 2020-Q3 |
2020-08-21 | - | Kvartalsrapport 2020-Q2 |
2020-05-08 | - | X-dag ordinarie utdelning PLUN 0.00 SEK |
2020-05-07 | - | Årsstämma |
2020-05-07 | - | Kvartalsrapport 2020-Q1 |
2020-02-13 | - | Bokslutskommuniké 2019 |
2019-10-24 | - | Kvartalsrapport 2019-Q3 |
2019-08-21 | - | Kvartalsrapport 2019-Q2 |
2019-05-17 | - | Årsstämma |
2019-05-08 | - | X-dag ordinarie utdelning PLUN 0.00 SEK |
2019-04-16 | - | Årsstämma |
2019-04-16 | - | Kvartalsrapport 2019-Q1 |
2019-02-22 | - | Bokslutskommuniké 2018 |
2018-11-14 | - | Kvartalsrapport 2018-Q3 |
2018-08-21 | - | Kvartalsrapport 2018-Q2 |
2018-05-17 | - | X-dag ordinarie utdelning PLUN 0.00 SEK |
2018-05-16 | - | Årsstämma |
2018-05-16 | - | Kvartalsrapport 2018-Q1 |
2018-02-28 | - | Bokslutskommuniké 2017 |
2017-11-16 | - | Kvartalsrapport 2017-Q3 |
2017-08-24 | - | Kvartalsrapport 2017-Q2 |
2017-05-10 | - | X-dag ordinarie utdelning PLUN 0.00 SEK |
2017-05-09 | - | Årsstämma |
2017-05-09 | - | Kvartalsrapport 2017-Q1 |
2017-02-23 | - | Bokslutskommuniké 2016 |
2016-11-10 | - | Kvartalsrapport 2016-Q3 |
2016-08-25 | - | Kvartalsrapport 2016-Q2 |
2016-05-18 | - | X-dag ordinarie utdelning PLUN 0.00 SEK |
2016-05-17 | - | Årsstämma |
2016-05-17 | - | Kvartalsrapport 2016-Q1 |
2016-02-26 | - | Bokslutskommuniké 2015 |
2015-11-13 | - | Kvartalsrapport 2015-Q3 |
2015-08-28 | - | Kvartalsrapport 2015-Q2 |
2015-05-12 | - | X-dag ordinarie utdelning PLUN 0.00 SEK |
2015-05-11 | - | Årsstämma |
2015-05-11 | - | Kvartalsrapport 2015-Q1 |
2015-02-27 | - | Bokslutskommuniké 2014 |
2014-11-28 | - | Kvartalsrapport 2014-Q3 |
2014-08-29 | - | Kvartalsrapport 2014-Q2 |
2014-05-14 | - | Kvartalsrapport 2014-Q1 |
2014-05-06 | - | X-dag ordinarie utdelning PLUN 0.00 SEK |
2014-05-05 | - | Årsstämma |
2014-02-22 | - | Bokslutskommuniké 2013 |
2013-11-20 | - | Kvartalsrapport 2013-Q3 |
Beskrivning
Land | Sverige |
---|---|
Lista | First North Stockholm |
Sektor | Hälsovård |
Industri | Medicinteknik |
Capio Urologi Solna has been named a CoreTherm Center of Excellence for 2022. Being named the CoreTherm Center of Excellence (COE) is proof of a high performance for both the clinic and the staff. At the same time, attention is drawn to the clinic's great commitment to provide significant, lasting symptom relief to men with benign prostate enlargement, where treatment with CoreTherm plays a central role in the care.
The CoreTherm Center of Excellence is defined as a clinic that has performed at least 100 CoreTherm treatments in the past year and where factors such as well-organized staff, level of education, experience, treatment routines, optimal equipment and facilities are of great importance for the result. These clinics therefore also have the opportunity to conduct training sessions for new CoreTherm users.
“Capio Urology Solna has in a short time gained a great deal of experience and a functioning organization to use CoreTherm as an effective treatment for symptoms of an enlarged prostate. I am very impressed. If you experience symptoms from a benign enlarged prostate, I can warmly recommend that you book an appointment with Capio Urologi Solna to see if CoreTherm is right for you.”, says CEO Johan Wennerholm in a comment.
For further information, please contact:
Johan Wennerholm, CEO
Tel. +46 (0) 730 429997
Email: johan.wennerholm@prostalund.com
About ProstaLund
ProstaLund AB is a Swedish medical technology company and a leading developer and manufacturer of innovative urological devices and treatments. The company’s lead product, CoreTherm, is a patented Thermotherapy treatment method for Benign Prostatic Hyperplasia (BPH) which can be tailored to suit the needs of each individual patient. CoreTherm is used today in hospitals and clinics in Sweden and worldwide. ProstaLund is listed on the Nasdaq First North Growth Market.
Certified Adviser:
Västra Hamnen Corporate Finance AB
Phone: +46 40 200 250
E-mail: ca@vhcorp.se